Dentalcare logo

Fundamentals of Dentifrice: Oral Health Benefits in a Tube | Dentalcare.ca

Course Number: 410

PDF

Take the Test

References / Additional Resources

  1. US Federal Food, Drug, & Cosmetic Act (FFDCA). 2018 Mar 29. Accessed June 17, 2020.

  2. Tenuta LM, Cury JA. Fluoride: its role in dentistry. Braz Oral Res. 2010;24 Suppl 1:9-17. doi:10.1590/s1806-83242010000500003.

  3. US FDA. Monograph System. Data Standards Manual (monographs). 2018 Feb 27. Accessed June 17, 2020.

  4. US Food & Drug Administration (FDA). Accessed June 17, 2020.

  5. American Dental Association (ADA). Seal of Acceptance Program. Accessed June 17, 2020.

  6. American Dental Association (ADA). Requirements for Product Acceptance. Accessed June 17, 2020.

  7. Ten Great Public Health Achievements - United States, 1900-1999, CDC Morbidity and Mortality Weekly Report 1999 Apr 02;48(12):241-243. Accessed June 17, 2020.

  8. Bratthall D, Hänsel-Petersson G, Sundberg H. Reasons for the caries decline: what do the experts believe?. Eur J Oral Sci. 1996;104(4 ( Pt 2)):416-432. doi:10.1111/j.1600-0722.1996.tb00104.x.

  9. Tenuta LM, Zamataro CB, Del Bel Cury AA, Tabchoury CP, Cury JA. Mechanism of fluoride dentifrice effect on enamel demineralization. Caries Res. 2009;43(4):278-285. doi:10.1159/000217860.

  10. Cury JA, do Amaral RC, Tenuta LM, Del Bel Cury AA, Tabchoury CP. Low-fluoride toothpaste and deciduous enamel demineralization under biofilm accumulation and sucrose exposure. Eur J Oral Sci. 2010;118(4):370-375. doi:10.1111/j.1600-0722.2010.00745.x.

  11. Muhler JC, Radike AW, Nebergall WH, Day HG. The effect of a stannous fluoride-containing dentifrice on caries reduction in children. J Dent Res. 1954;33(5):606-612. doi:10.1177/00220345540330050401.

  12. Muhler JC, Radike AW. Effect of a dentifrice containing stannous fluoride on dental caries in adults. II. Results at the end of two years of unsupervised use. J Am Dent Assoc. 1957;55(2):196-198. doi:10.14219/jada.archive.1957.0157.

  13. American Dental Association, Council on Dental Therapeutics: Evaluation of Crest toothpaste. JADA. 1960 Aug;61(2):272-275.

  14. Chace R, American Dental Association. Reclassification of Crest toothpaste; Council on Dental Therapeutics. J Am Dent Assoc. 1964;69:195-196.

  15. Chronology of important chemical and related events since 1876. Chemical and Engineering News April 6th, 1976: 91-92.

  16. Featherstone JD. The caries balance: the basis for caries management by risk assessment. Oral Health Prev Dent. 2004;2 Suppl 1:259-264.

  17. Fejerskov O. Concepts of dental caries and their consequences for understanding the disease. Community Dent Oral Epidemiol. 1997;25(1):5-12. doi:10.1111/j.1600-0528.1997.tb00894.x.

  18. Silverstone LM. Laboratory studies on the demineralization and remineralization of human enamel in relation to caries mechanisms. Aust Dent J. 1980;25(3):163-168. doi:10.1111/j.1834-7819.1980.tb03707.x.

  19. Cury JA, Tenuta LM. Enamel remineralization: controlling the caries disease or treating early caries lesions?. Braz Oral Res. 2009;23 Suppl 1:23-30. doi:10.1590/s1806-83242009000500005.

  20. Posner AS. The mineral of bone. Clin Orthop Relat Res. 1985;(200):87-99.

  21. Dijkman A, Huizinga E, Ruben J, Arends J. Remineralization of human enamel in situ after 3 months: the effect of not brushing versus the effect of an F dentifrice and an F-free dentifrice. Caries Res. 1990;24(4):263-266. doi:10.1159/000261280.

  22. Clarkson JE, Ellwood RP, Chandler RE. A comprehensive summary of fluoride dentifrice caries clinical trials. Am J Dent. 1993;6 Spec No:S59-S106.

  23. White DJ. A "return" to stannous fluoride dentifrices. J Clin Dent. 1995;6 Spec No:29-36.

  24. Baig A, He T. A novel dentifrice technology for advanced oral health protection: A review of technical and clinical data. Compend Contin Educ Dent. 2005;26(9 Suppl 1):4-11.

  25. BIBBY BG. Fluoride mouthwashes, fluoride dentifrices, and other uses of fluorides in control of caries. J Dent Res. 1948;27(3):367-375. doi:10.1177/00220345480270031301.

  26. Stookey GK. Are all fluoride dentifrices the same? In: Wei SHY Clinical uses of fluoride. Lea & Febiger 1985, Philadelphia.

  27. Zacherl WA. A three-year clinical caries evaluation of the effect of a sodium fluoride-silica abrasive dentifrice. Pharmacol Ther Dent. 1981;6(1-2):1-7.

  28. Beiswanger BB, Gish CW, Mallatt ME. A three-year study of the effect of a sodium fluoride-silica abrasive dentifrice on dental caries. Pharmacol Ther Dent. 1981;6(1-2):9-16.

  29. Colgate Cavity Protection Information. Colgate-Cavity-Protection-Toothpaste/specifics. Accessed June 17, 2020.

  30. Shellis RP, Duckworth RM. Studies on the cariostatic mechanisms of fluoride. Int Dent J. 1994;44(3 Suppl 1):263-273.

  31. American Dental Association. Joint Report of the American Dental Association Council on Access, Prevention and Interprofessional Relations and Council on Scientific Affairs to the House of Delegates: Response to Resolution 73H-2000. 2001 Oct. Accessed June 17, 2020.

  32. Imfeld T. Dental erosion. Definition, classification and links. Eur J Oral Sci. 1996;104(2 ( Pt 2)):151-155. doi:10.1111/j.1600-0722.1996.tb00063.x.

  33. ten Cate JM, Imfeld T. Dental erosion, summary. Eur J Oral Sci. 1996;104(2 ( Pt 2)):241-244. doi:10.1111/j.1600-0722.1996.tb00073.x.

  34. Johansson AK, Lingström P, Imfeld T, Birkhed D. Influence of drinking method on tooth-surface pH in relation to dental erosion. Eur J Oral Sci. 2004;112(6):484-489. doi:10.1111/j.1600-0722.2004.00172.x.

  35. Hooper SM, Newcombe RG, Faller R, Eversole S, Addy M, West NX. The protective effects of toothpaste against erosion by orange juice: studies in situ and in vitro. J Dent. 2007;35(6):476-481. doi:10.1016/j.jdent.2007.01.003.

  36. Huysmans MC, Jager DH, Ruben JL, Unk DE, Klijn CP, Vieira AM. Reduction of erosive wear in situ by stannous fluoride-containing toothpaste. Caries Res. 2011;45(6):518-523. doi:10.1159/000331391.

  37. https://pubmed.ncbi.nlm.nih.gov/24571704[Bellamy PG, Harris R, Date RF, et al. In situ clinical evaluation of a stabilised, stannous fluoride dentifrice [published correction appears in Int Dent J. 2014 Jun;64(3):171. Manly, Andrew [corrected to Manley, Andrew]]. Int Dent J. 2014;64 Suppl 1:43-50. doi:10.1111/idj.12102.]()

  38. Faller RV, Eversole SL. Enamel protection from acid challenge--benefits of marketed fluoride dentifrices. J Clin Dent. 2013;24(1):25-30.

  39. Eversole SL, Saunders-Burkhardt K, Faller RV. Erosion protection comparison of stabilised SnF2 , mixed fluoride active and SMFP/arginine-containing dentifrices. Int Dent J. 2014;64 Suppl 1:22-28. doi:10.1111/idj.12099.

  40. Eversole SL, Saunders-Burkhardt K, Faller RV. Erosion Prevention Potential of an Over-the-Counter Stabilized SnF2 Dentifrice Compared to 5000 ppm F Prescription-Strength Products. J Clin Dent. 2015;26(2):44-49.

  41. Faller RV, Eversole SL, Tzeghai GE. Enamel protection: a comparison of marketed dentifrice performance against dental erosion. Am J Dent. 2011;24(4):205-210.

  42. Baig AA, Faller RV, Yan J, Ji N, Lawless M, Eversole SL. Protective effects of SnF2 - Part I. Mineral solubilisation studies on powdered apatite. Int Dent J. 2014;64 Suppl 1:4-10. doi:10.1111/idj.12096.

  43. Khambe D, Eversole SL, Mills T, Faller RV. Protective effects of SnF2 - Part II. Deposition and retention on pellicle-coated enamel. Int Dent J. 2014;64 Suppl 1:11-15. doi:10.1111/idj.12097.

  44. Faller RV, Eversole SL. Protective effects of SnF2 - Part III. Mechanism of barrier layer attachment. Int Dent J. 2014;64 Suppl 1:16-21. doi:10.1111/idj.12098.

  45. Lussi A, Carvalho TS. The future of fluorides and other protective agents in erosion prevention. Caries Res. 2015;49 Suppl 1:18-29. doi:10.1159/000380886.

  46. Ramji N, Baig A, He T, et al. Sustained antibacterial actions of a new stabilized stannous fluoride dentifrice containing sodium hexametaphosphate. Compend Contin Educ Dent. 2005;26(9 Suppl 1):19-28.

  47. Mankodi S, Bartizek RD, Winston JL, Biesbrock AR, McClanahan SF, He T. Anti-gingivitis efficacy of a stabilized 0.454% stannous fluoride/sodium hexametaphosphate dentifrice. J Clin Periodontol. 2005;32(1):75-80. doi:10.1111/j.1600-051X.2004.00639.x.

  48. Baig A, He T, Buisson J, Sagel L, Suszcynsky-Meister E, White DJ. Extrinsic whitening effects of sodium hexametaphosphate—a review including a dentifrice with stabilized stannous fluoride. Compend Contin Educ Dent. 2005;26(9 Suppl 1):47-53.

  49. Terézhalmy G, Chaves E, Bsoul S, Baker R, He T. Clinical evaluation of the stain removal efficacy of a novel stannous fluoride and sodium hexametaphosphate dentifrice. Am J Dent. 2007;20(1):53-58.

  50. Schiff T, He T, Sagel L, Baker R. Efficacy and safety of a novel stabilized stannous fluoride and sodium hexametaphosphate dentifrice for dentinal hypersensitivity. J Contemp Dent Pract. 2006;7(2):1-8. Published 2006 May 1.

  51. Johnson G, Brännström M. The sensitivity of dentin. Changes in relation to conditions at exposed tubule apertures. Acta Odontol Scand. 1974;32(1):29-38. doi:10.3109/00016357409002530.

  52. Närhi MV. Dentin sensitivity: a review. J Biol Buccale. 1985 Jun;13(2):75-96.

  53. Cox CF. Etiology and treatment of root hypersensitivity. Am J Dent. 1994;7(5):266-270.

  54. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997;24(11):808-813. doi:10.1111/j.1600-051x.1997.tb01194.x.

  55. Irwin CR, McCusker P. Prevalence of dentine hypersensitivity in a general dental population. J Ir Dent Assoc. 1997;43(1):7-9.

  56. Marieb EN, Hoehn K. Human anatomy and physiology. 7th ed. San Francisco CA: Pearson Benjamin Cummings. 2007.

  57. Brännström M, Johnson G, Nordenvall KJ. Transmission and control of dentinal pain: resin impregnation for the desensitization of dentin. J Am Dent Assoc. 1979;99(4):612-618. doi:10.14219/jada.archive.1979.0337.

  58. Petrou I, Heu R, Stranick M, et al. A breakthrough therapy for dentin hypersensitivity: how dental products containing 8% arginine and calcium carbonate work to deliver effective relief of sensitive teeth. J Clin Dent. 2009;20(1):23-31.

  59. Litkowski L, Greenspan DC. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity--proof of principle. J Clin Dent. 2010;21(3):77-81.

  60. Gendreau L, Barlow AP, Mason SC. Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity. J Clin Dent. 2011;22(3):90-95.

  61. White DJ, Lawless MA, Fatade A, et al. Stannous fluoride/sodium hexametaphosphate dentifrice increases dentin resistance to tubule exposure in vitro. J Clin Dent. 2007;18(2):55-59.

  62. Stookey GK, Mau MS, Isaacs RL, Gonzalez-Gierbolini C, Bartizek RD, Biesbrock AR. The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico. Caries Res. 2004;38(6):542-550. doi:10.1159/000080584.

  63. Mallatt M, Mankodi S, Bauroth K, Bsoul SA, Bartizek RD, He T. A controlled 6-month clinical trial to study the effects of a stannous fluoride dentifrice on gingivitis. J Clin Periodontol. 2007;34(9):762-767. doi:10.1111/j.1600-051X.2007.01109.x.

  64. Schiff T, Saletta L, Baker RA, Winston JL, He T. Desensitizing effect of a stabilized stannous fluoride/Sodium hexametaphosphate dentifrice. Compend Contin Educ Dent. 2005;26(9 Suppl 1):35-40.

  65. Jin Y, Yip HK. Supragingival calculus: formation and control. Crit Rev Oral Biol Med. 2002;13(5):426-441. doi:10.1177/154411130201300506.

  66. Bollmer BW, Sturzenberger OP, Vick V, Grossman E. Reduction of calculus and Peridex stain with Tartar-Control Crest. J Clin Dent. 1995;6(4):185-187.

  67. Pradeep AR, Agarwal E, P AR, Rao MS, Faizuddin M. Study of orthophosphate, pyrophosphate, and pyrophosphatase in saliva with reference to calculus formation and inhibition. J Periodontol. 2011;82(3):445-451. doi:10.1902/jop.2010.100355.

  68. White DJ. A new and improved "dual action" whitening dentifrice technology—sodium hexametaphosphate. J Clin Dent. 2002;13(1):1-5.

  69. White D, Cox E, Suszcynskymeister E, Baig AA. In vitro studies of the anticalculus efficacy of a sodium hexametaphosphate whitening dentifrice. J Clin Dent. 2002;13(1):33-37.

  70. Segreto VA, Collins EM, D'Agostino R, Cancro LP, Pfeifer HJ, Gilbert RJ. Anticalculus effect of a dentifrice containing 0.5% zinc citrate trihydrate. Community Dent Oral Epidemiol. 1991;19(1):29-31. doi:10.1111/j.1600-0528.1991.tb00100.x.

  71. Hattab FN, Qudeimat MA, al-Rimawi HS. Dental discoloration: an overview. J Esthet Dent. 1999;11(6):291-310. doi:10.1111/j.1708-8240.1999.tb00413.x.

  72. Schemehorn BR, Moore MH, Putt MS. Abrasion, polishing, and stain removal characteristics of various commercial dentifrices in vitro. J Clin Dent. 2011;22(1):11-18.

  73. Hefferren JJ. A laboratory method for assessment of dentrifrice abrasivity. J Dent Res. 1976;55(4):563-573. doi:10.1177/00220345760550040301.

  74. St John S, White DJ. History of the Development of Abrasivity Limits for Dentifrices. J Clin Dent. 2015;26(2):50-54.

  75. He T, Baker R, Bartizek RD, Biesbrock AR, Chaves E, Terézhalmy G. Extrinsic stain removal efficacy of a stannous fluoride dentifrice with sodium hexametaphosphate. J Clin Dent. 2007;18(1):7-11.

  76. Haywood VB, Heymann HO. Nightguard vital bleaching. Quintessence Int. 1989;20(3):173-176.

  77. Dorfman WM. News from Procter and Gamble (P&G) introducing Crest Whitestrips, their new over-the-counter whitening product. J N J Dent Assoc. 2000 Fall;71(4):7, 10.

  78. Feng X, Chen X, Cheng R, Sun L, Zhang Y, He T. Breath malodor reduction with use of a stannous-containing sodium fluoride dentifrice: a meta-analysis of four randomized and controlled clinical trials. Am J Dent. 2010;23 Spec No B:27B-31B.

  79. Bosy A. Oral malodor: philosophical and practical aspects. J Can Dent Assoc. 1997;63(3):196-201.

  80. Liu XN, Shinada K, Chen XC, Zhang BX, Yaegaki K, Kawaguchi Y. Oral malodor-related parameters in the Chinese general population. J Clin Periodontol. 2006;33(1):31-36. doi:10.1111/j.1600-051X.2005.00862.x.

  81. Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation between volatile sulphur compounds and certain oral health measurements in the general population. J Periodontol. 1995;66(8):679-684. doi:10.1902/jop.1995.66.8.679.

  82. Ayo-Yusuf OA, Van Wyk C, Van Wyk P. Oral malodour among patients attending a preventive clinic in Pretoria. J Dent Res 2005;84 Sp Iss B).

  83. Iwanicka-Grzegorek E, Michalik J, Kepa J, Wierzbicka M, Aleksinski M, Pierzynowska E. Subjective patients' opinion and evaluation of halitosis using halimeter and organoleptic scores. Oral Dis. 2005;11 Suppl 1:86-88. doi:10.1111/j.1601-0825.2005.01101.x.

  84. Bornstein MM, Kislig K, Hoti BB, Seemann R, Lussi A. Prevalence of halitosis in the population of the city of Bern, Switzerland: a study comparing self-reported and clinical data. Eur J Oral Sci. 2009;117(3):261-267. doi:10.1111/j.1600-0722.2009.00630.x.

  85. Preti G, Clark L, Cowart BJ, et al. Non-oral etiologies of oral malodor and altered chemosensation. J Periodontol. 1992;63(9):790-796. doi:10.1902/jop.1992.63.9.790.

  86. ADA Council on Scientific Affairs. Oral malodor. J Am Dent Assoc. 2003;134(2):209-214. doi:10.14219/jada.archive.2003.0135.

  87. Kleinberg I, Westbay G. Salivary and metabolic factors involved in oral malodor formation. J Periodontol. 1992 Sep;63(9):768-775. doi: 10.1902/jop.1992.63.9.768.

  88. Rosenberg M. The science of bad breath. Sci Am. 2002;286(4):72-79. doi:10.1038/scientificamerican0402-72.

  89. Rosenberg M. Bad breath: Research perspectives. Ramat Aviv: Ramot Publishing-Tel Aviv University 1997.

  90. Haraszthy VI, Zambon JJ, Sreenivasan PK, et al. Identification of oral bacterial species associated with halitosis. J Am Dent Assoc. 2007;138(8):1113-1120. doi:10.14219/jada.archive.2007.0325.

  91. De Boever EH, Loesche WJ. Assessing the contribution of anaerobic microflora of the tongue to oral malodor. J Am Dent Assoc. 1995;126(10):1384-1393. doi:10.14219/jada.archive.1995.0049.

  92. Rosenberg M. Clinical assessment of bad breath: current concepts [published correction appears in J Am Dent Assoc 1996 May;127(5):570]. J Am Dent Assoc. 1996;127(4):475-482. doi:10.14219/jada.archive.1996.0239.

  93. Lee CH, Kho HS, Chung SC, Lee SW, Kim YK. The relationship between volatile sulfur compounds and major halitosis-inducing factors. J Periodontol. 2003;74(1):32-37. doi:10.1902/jop.2003.74.1.32.

  94. Yaegaki K, Sanada K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J Periodontal Res. 1992;27(4 Pt 1):233-238. doi:10.1111/j.1600-0765.1992.tb01673.x.

  95. Ratcliff PA, Johnson PW. The relationship between oral malodor, gingivitis, and periodontitis. A review. J Periodontol. 1999;70(5):485-489. doi:10.1902/jop.1999.70.5.485.

  96. Bakdash B. Current patterns of oral hygiene product use and practices. Periodontol 2000. 1995;8:11-14. doi:10.1111/j.1600-0757.1995.tb00041.x.

  97. van der Weijden GA, Hioe KP. A systematic review of the effectiveness of self-performed mechanical plaque removal in adults with gingivitis using a manual toothbrush. J Clin Periodontol. 2005;32 Suppl 6:214-228. doi:10.1111/j.1600-051X.2005.00795.x.

  98. Farrell S, Barker ML, Gerlach RW. Overnight malodor effect with a 0.454% stabilized stannous fluoride sodium hexametaphosphate dentifrice. Compend Contin Educ Dent. 2007;28(12):658-671.

  99. Tinanoff N. Progress regarding the use of stannous fluoride in clinical dentistry. J Clin Dent. 1995;6 Spec No:37-40.

  100. Donovan-Brand R. A comparison of the breath and antimicrobial efficacies of various antimicrobial systems present in commercial dental products. J Dent Res 2003; 82 (Sp Iss):501.

  101. Navada R, Kumari H, Le S, Zhang J. Oral malodor reduction from a zinc-containing toothpaste. J Clin Dent. 2008;19(2):69-73.

  102. Chen X, He T, Sun L, Zhang Y, Feng X. A randomized cross-over clinical trial to evaluate the effect of a 0.454% stannous fluoride dentifrice on the reduction of oral malodor. Am J Dent. 2010;23(3):175-178.

  103. Mäkinen KK. Sugar alcohol sweeteners as alternatives to sugar with special consideration of xylitol. Med Princ Pract. 2011;20(4):303-320. doi:10.1159/000324534.

Additional Resources


No Additional Resources Available

0/25Next